[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Michigan_Value Avatar @Michigan_Value Michigan Value Investor

Michigan Value Investor posts on X about $eton, eton, $hrow, $qubt the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence finance XXXXX% stocks XXXXX% cryptocurrencies XXXXX%

Social topic influence $eton #1, eton #33, $hrow #7, $qubt #7, ceo 15.38%, $hrows #1, $275m #2, $ionq #32, $gme #448, $qbts #17

Top accounts mentioned or mentioned by @genejchan @oddhootcapital @commonsenseplay @apphyd @app_hyd @jfais20

Top assets mentioned Quantum Computing Inc. (QUBT) IonQ, Inc. (IONQ) GameStop, Corp. (GME) D-Wave Quantum Inc. (QBTS) Rigetti Computing, Inc. Common Stock (RGTI) MemeCoin (MEME) SPDR S&P XXX ETF Trust (SPY)

Top Social Posts

Top posts by engagements in the last XX hours

"$ETON presentation today path $500M revenue. CEO underpromise/overdeliver kind of guy so far"
X Link 2025-12-04T14:46Z 1355 followers, 1346 engagements

"Deep dive on $HROW's Dry Eye Disease drug Vevye. DED market today $2B growing XX% CAGR. Why Read on. Vevye Q4 XX XX% share up from X% in Q1 about to accelerate. Why Read on. HROW 2025 revenue $275M. Vevye $100M in XX $300M in XX $2B in 2030. Why Read on"
X Link 2025-12-05T15:41Z 1355 followers, 7745 engagements

"By Jan 2024 two vastly better drugs are available Miebo & Vevye. Work better faster limited side effects. DED market growing at XX% CAGR as patients return and try new drugs and many of them benefit. 2030 US DED market $6B at this pace"
X Link 2025-12-05T15:41Z 1355 followers, XXX engagements

"$HROW's Vevye is the best drug. It does everything $BLCO's Miebo does & also treats inflammation which presents in almost all DED cases. Both are good drugs poor but improving insurance coverage. Coverage takes time but improves with share"
X Link 2025-12-05T15:41Z 1355 followers, XXX engagements

"$HROW reveals internal expectations for Lucentis/Eylea biosimilars: $240M-$320M run rate by 2H 2027 compare to total company revenue of $275M in 2025"
X Link 2025-12-03T12:15Z 1356 followers, 11.9K engagements

"@app_hyd $ETON spun out of $HROW yet another creation of CEO Mark Baum this time in partnership with ETON CEO Sean Brynjelsen. Deep dive:"
X Link 2025-12-04T18:42Z 1356 followers, XXX engagements

"$SPY $QQQ article and it's free you lucky duckies I own $HROW and $ETON & some other things but NO BETA"
X Link 2025-12-10T16:13Z 1356 followers, XXX engagements

"@genejchan $IONQ will trade at cash/share or maybe a bit more or even less since they burn cash. Time frame TBD. Also true of $QBTS $QUBT and $RGTI. See $GME for an example of how this works with $MEME stocks. Some people made money on $GME but Hodling at those bubble prices was a mistake"
X Link 2025-12-11T14:52Z 1356 followers, XXX engagements

"$IONQ will trade at cash/share or maybe a bit more or even less since they burn cash. Time frame TBD. Also true of $QBTS $QUBT and $RGTI. See $GME for an example of how this works with $MEME stocks. Some people made money on $GME but Hodling at those bubble prices was a mistake"
X Link 2025-12-11T14:52Z 1356 followers, XXX engagements

"@Oddhootcapital Alternatively this time isn't different"
X Link 2025-12-11T17:59Z 1356 followers, XX engagements

"@genejchan Interested in your take on why $QUBT market cap is only $2.8B. Any thoughts on why that is"
X Link 2025-12-11T18:19Z 1356 followers, XX engagements